Palbociclib (Ibrance) and Ketamine Therapy | Tovani Health
Ibrance (Palbociclib) — CDK4/6 inhibitor (HR+/HER2- breast cancer)
Verdict at Tovani Health
Fully compatible; the strong-CYP3A4-inhibitor caution is a palbociclib dose conversation, not KAP.
Palbociclib and ketamine have no direct clinically significant interaction. Used with endocrine therapy (letrozole, fulvestrant) for HR+/HER2- breast cancer. The intrinsic interaction story you'll hear about — palbociclib is a CYP3A4 substrate raised by strong inhibitors like clarithromycin, Paxlovid, and grapefruit — is about palbociclib toxicity, not about KAP. Same conversation with abemaciclib and ribociclib. Neutropenia monitoring is intrinsic and unchanged by KAP.
If you take Ibrance regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Ibrance interacts with ketamine
Palbociclib inhibits CDK4 and CDK6, halting cancer cells in G1 phase. CYP3A4 substrate and weak time-dependent inhibitor; the substrate effect dominates clinically.
What we do at intake
Continue as prescribed. Tell us if you're on any concurrent CYP3A4 modulators — that's a palbociclib safety issue independent of KAP.
Bottom line
Palbociclib and ketamine have no direct clinically significant interaction. Used with endocrine therapy (letrozole, fulvestrant) for HR+/HER2- breast cancer. The intrinsic interaction story you'll hear about — palbociclib is a CYP3A4 substrate raised by strong inhibitors like clarithromycin, Paxlovid, and grapefruit — is about palbociclib toxicity, not about KAP. Same conversation with abemaciclib and ribociclib. Neutropenia monitoring is intrinsic and unchanged by KAP.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Ibrance (Palbociclib) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 22, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.